Read More

Tesla Struggles with Delivery Goals and AI Tech Expectations, Analysts Adjust Financial Forecasts

Truist Securities analyst reiterates Tesla (TSLA) as Hold, lowers price target from $193 to $176. Lowered estimates for deliveries, revenue, & EPS in 2024 & 2025 due to production and demand concerns. Next catalysts: next-gen vehicle unveiling & sale. HSBC analyst also lowers price target.

PP

Read More

Citi Monitors Competitive Threats To Eli Lilly, Says It Is Positioned To Maintain Leadership And Expand

Citi Research raises price target for Eli Lilly, citing improved risk-adjusted sales outlook for GLP-1 agonist orforglipron. With Phase 3 trials ongoing since 2023, concerns about liver toxicity diminish. Analysts foresee potential sales surpassing $85 billion, closely watching competitive landscape.

LLY